Viking Therapeutics (VKTX) Tops Q3 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Boeing wins $121 million Navy contract for P-8A upgrades
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg